| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2002;40:342.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Hypertension and Stroke Research Laboratories, Department of Physiology, University of Sydney, and Department of Neurosurgery, Royal North Shore Hospital, Sydney, Australia.
Correspondence to Associate Professor Paul M. Pilowsky, Hypertension and Stroke Research Laboratories, Ground Floor, Block 3, Royal North Shore Hospital, Sydney, 2065, Australia. E-mail pilowsky{at}med.usyd.edu.au
In this study we aimed to determine whether the levels of gene expression for phenylethanolamine-N-methyltransferase (PNMT), noradrenaline transporter (NAT),
1A-receptor (
1A-R), and
2A-receptor (
2A-R) vary with resting systolic blood pressure in spontaneously hypertensive rats (SHR) compared with normotensive Wistar-Kyoto (WKY) or Sprague-Dawley (SD) rats. Sites examined included central and peripheral regions associated with the control of arterial pressure. Twenty week old SD (n=6), WKY (n=6), and SHR (n=6) were used. Systolic blood pressure was measured using tail cuff plethysmography 2 weeks before tissue extraction. RNA was isolated and reverse-transcribed into cDNA. Gene expression levels were measured, using quantitative real time PCR, relative to the expression of GAPDH. PNMT, NAT, and
1A-R mRNA expression was significantly greater in SHR tissue samples compared with normotensives. In the rostral ventrolateral medulla, PNMT mRNA in SHR was 3 times greater than that in WKY (SHR: 0.82±0.02%; WKY: 0.29±0.02%). The amount of
2A-R mRNA was significantly lower in SHR compared with normotensives. For example, the level of
2A-R mRNA in spinal cord of SHR was 3 times less than that found in WKY (SHR: 1.85±0.04%; WKY: 3.26±0.07%). PNMT, NAT, and
1A-R mRNA levels were positively correlated with systolic blood pressure in all central tissue investigated. Conversely,
2A-R mRNA levels in central sites were negatively correlated with systolic blood pressure. Clearly, a decrease in central
2A-R and an increase in
1A-R is consistent with the elevated blood pressure and sympathetic activity observed in SHR.
Key Words: catecholamines hypertension, genetic receptors, adrenergic alpha renin-angiotensin system sympathetic nervous system
This article has been cited by other articles:
![]() |
A. G. Teschemacher, S. Wang, M. K. Raizada, J. F.R. Paton, and S. Kasparov Area-Specific Differences in Transmitter Release in Central Catecholaminergic Neurons of Spontaneously Hypertensive Rats Hypertension, August 1, 2008; 52(2): 351 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
A L Markel, O E Redina, M A Gilinsky, G M Dymshits, E V Kalashnikova, Y. V Khvorostova, L A Fedoseeva, and G S Jacobson Neuroendocrine profiling in inherited stress-induced arterial hypertension rat strain with stress-sensitive arterial hypertension J. Endocrinol., December 1, 2007; 195(3): 439 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Manni, A. Holmang, S. Cajander, T. Lundeberg, L. Aloe, and E. Stener-Victorin Effect of anti-NGF on ovarian expression of {alpha}1- and beta2-adrenoceptors, TrkA, p75NTR, and tyrosine hydroxylase in rats with steroid-induced polycystic ovaries Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R826 - R835. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Debrus, L. Rahbani, M. Marttila, B. Delorme, P. Paradis, and M. Nemer The Zinc Finger-Only Protein Zfp260 Is a Novel Cardiac Regulator and a Nuclear Effector of {alpha}1-Adrenergic Signaling Mol. Cell. Biol., October 1, 2005; 25(19): 8669 - 8682. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Veerasingham, M. Yamazato, K. H. Berecek, J. M. Wyss, and M. K. Raizada Increased PI3-Kinase in Presympathetic Brain Areas of the Spontaneously Hypertensive Rat Circ. Res., February 18, 2005; 96(3): 277 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lonergan, A. G. Teschemacher, D. Y. Hwang, K.-S. Kim, A. E. Pickering, and S. Kasparov Targeting brain stem centers of cardiovascular control using adenoviral vectors: impact of promoters on transgene expression Physiol Genomics, January 20, 2005; 20(2): 165 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. J. Kuo, C. J. Lai, F.-Z. Shaw, C.-W. Lai, and C. C. H. Yang Sleep-related sympathovagal imbalance in SHR Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1170 - H1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hao, M. Du, A. Lopez-Campistrous, and C. Fernandez-Patron Agonist-Induced Activation of Matrix Metalloproteinase-7 Promotes Vasoconstriction Through the Epidermal Growth Factor-Receptor Pathway Circ. Res., January 9, 2004; 94(1): 68 - 76. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |